FibroGen Ownership | Who Owns FibroGen?


OverviewForecastRevenueFinancialsChartTranscripts

FibroGen Ownership Summary


FibroGen is owned by 5.60% institutional investors, 1.57% insiders, and 92.83% retail investors. Armistice capital is the largest institutional shareholder, holding 9.35% of FGEN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.89% of its assets in FibroGen shares.

FGEN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFibroGen5.60%1.57%92.83%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital378.00K9.35%$4.63M
Vanguard group184.24K4.56%$2.26M
Acadian asset management110.28K2.73%$1.35M
Blackrock2.41M2.43%$2.15M
Jacobs levy equity management2.10M2.13%$1.88M
Blackrock funding, inc. /de84.75K2.10%$1.04M
Marshall wace, llp72.45K1.79%$887.50K
Primecap management co/ca/58.88K1.46%$721.27K
Aqr capital management1.32M1.33%$1.18M
Geode capital management43.68K1.08%$535.23K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Armistice capital378.00K0.07%$4.63M
Jacobs levy equity management2.10M0.01%$1.88M
Drw securities11.21K0.00%$137.38K
Acadian asset management110.28K0.00%$1.35M
Aqr capital management1.32M0.00%$1.18M
Cubist systematic strategies287.33K0.00%$256.39K
Marshall wace, llp72.45K0.00%$887.50K
Two sigma investments, lp40.22K0.00%$492.67K
Primecap management co/ca/58.88K0.00%$721.27K
Hightower advisors39.75K0.00%$486.89K

Top Buyers

HolderShares% AssetsChange
Aqr capital management1.32M0.00%769.59K
Cubist systematic strategies287.33K0.00%280.16K
Nomura139.60K0.00%139.60K
Susquehanna group, llp134.21K-78.85K
Armistice capital378.00K0.07%42.00K

Top Sellers

HolderShares% AssetsChange
Blackrock2.41M--4.56M
683 capital management---2.14M
Gsa capital partners llp---1.10M
Point72 asset management---1.08M
Pennant investors, lp---768.40K

New Positions

HolderShares% AssetsChangeValue
Nomura139.60K0.00%139.60K$124.56K
Squarepoint ops16.37K0.00%16.37K$200.53K
Drw securities11.21K0.00%11.21K$137.38K
Parallax volatility advisers10.00K-10.00K$8.92K
Macquarie group4.65K-4.65K$4.15K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-1.00
Point72 (difc)-13.00
Nelson, van denburg & campbell wealth management group-35.00
Southstate-105.00
Nisa investment advisors-120.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20256-79.31%226,362-78.61%50.82%2-50.00%--100.00%
Jun 30, 202530-46.43%1,060,110-96.79%262.46%5-76.19%2460.00%
Mar 31, 202556-20.00%32,974,661-9.03%322.51%21-16.00%15-37.50%
Dec 31, 202470-4.11%36,247,264-21.09%361.73%2525.00%24-20.00%
Sep 30, 202473-33.64%45,933,468-18.80%451.40%22-59.26%29-21.62%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.92M2.89%-1.00
Vanguard Total Stock Mkt Idx Inv114.18K2.82%-2.50K
PRIMECAP Odyssey Aggressive Growth2.64M2.63%-1.27M
Vanguard Capital Opportunity Inv67.98K1.68%-56.34K
PRIMECAP Odyssey Growth1.57M1.56%-826.01K
Vanguard Institutional Extnd Mkt Idx Tr37.95K0.94%-17.29K
Vanguard Strategic Small-Cap Equity Inv898.60K0.89%-
Fidelity Extended Market Index22.05K0.55%-181.00
Fidelity Enhanced Small Cap ETF361.69K0.36%527.00
NT R2000 Value Index Fund - NL308.69K0.31%34.29K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 13, 2025Wettig Thane CEOBuy$9.18K
Nov 17, 2025Wettig Thane CEOBuy$24.57K
Jun 30, 2025Schoeneck James A-Buy$119.48K
Mar 24, 2025Wettig Thane CEOBuy$50.66K
Mar 21, 2025Schoeneck James A-Buy$17.04K

Insider Transactions Trends


DateBuySell
2025 Q42-
2025 Q3--
2025 Q21-
2025 Q13-
2024 Q4--

FGEN Ownership FAQ


Who Owns FibroGen?

FibroGen shareholders are primarily institutional investors at 5.60%, followed by 1.57% insiders and 92.83% retail investors. The average institutional ownership in FibroGen's industry, Biotech Stocks , is 45.22%, which FibroGen falls below.

Who owns the most shares of FibroGen?

FibroGen’s largest shareholders are Armistice capital (378K shares, 9.35%), Vanguard group (184.24K shares, 4.56%), and Acadian asset management (110.28K shares, 2.73%). Together, they hold 16.64% of FibroGen’s total shares outstanding.

Does Blackrock own FibroGen?

Yes, BlackRock owns 2.43% of FibroGen, totaling 2.41M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 2.15M$. In the last quarter, BlackRock decreased its holdings by -4.558M shares, a -65.42% change.

Who is FibroGen’s biggest shareholder by percentage of total assets invested?

Armistice capital is FibroGen’s biggest shareholder by percentage of total assets invested, with 0.07% of its assets in 378K FibroGen shares, valued at 4.63M$.

Who is the top mutual fund holder of FibroGen shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of FibroGen shares, with 2.89% of its total shares outstanding invested in 2.92M FibroGen shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools